Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.

@article{Cheung2006SerumBM,
  title={Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.},
  author={Alfred K. Cheung and Michael V. Rocco and Guofen Yan and John Ken Leypoldt and Nathan W. Levin and Tom Greene and Lawrence Agodoa and Jeannie Bailey and Gerald J. Beck and William P. Clark and AndrewS. Levey and Daniel B. Ornt and Gerald I Schulman and Steven Schwab and Brendan P. Teehan and G. Garabed Eknoyan},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2006},
  volume={17 2},
  pages={
          546-55
        }
}
In the randomized Hemodialysis (HEMO) Study, chronic high-flux dialysis, as defined by higher beta-2 microglobulin (beta(2)M) clearance, compared with low-flux dialysis did not significantly alter all-cause mortality in the entire cohort but was associated with lower mortality in long-term dialysis patients. This analysis examined the determinants of serum beta(2)M levels and the associations of serum beta(2)M levels or dialyzer beta(2)M clearance with mortality. In a multivariable regression… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 138 CITATIONS, ESTIMATED 56% COVERAGE

250 Citations

0102030'08'11'14'17
Citations per Year
Semantic Scholar estimates that this publication has 250 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Keshaviah PR; for the Hemodialysis (HEMO) Study: Hemo 554 Journal of the American Society of Nephrology

  • JK Leypoldt, AK Cheung, L Agodoa, JT Daugirdas, T Greene
  • J Am Soc Nephrol
  • 2006

Similar Papers

Loading similar papers…